Form 4 for TPST Tempest Therapeutics, Inc.
Accepted 2024-07-03 00:00:00 ET · period of report 2024-07-02 · accession 0001415889-24-019279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-03 | 2024-07-02 | TPST | Whiting Samuel | Chief Medical Off | P - Purchase | $2.13 | +4,672 | 9,573 | +95% | +$9,951 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-02 | P | A | 4,672 | $2.13 | 9,573 | D | — | — | (F1) Includes 3,000 shares acquired under the Issuer's stock purchase plan. |